Amgen scores positive PhIII cardio outcomes for its PCSK9 franchise drug Repatha
Amgen got another round of good news for its PCSK9 franchise drug Repatha. Hot on the heels of a major patent fight victory over Sanofi …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
